These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT]. Lichy MP, Henze M, Plathow C, Bachert P, Kauczor HU, Schlemmer HP. Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287 [Abstract] [Full Text] [Related]
7. FDG transport and phosphorylation in human gliomas measured with dynamic PET. Herholz K, Rudolf J, Heiss WD. J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262 [Abstract] [Full Text] [Related]
8. Glucose consumption in recurrent gliomas. Ishikawa M, Kikuchi H, Miyatake S, Oda Y, Yonekura Y, Nishizawa S. Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844 [Abstract] [Full Text] [Related]
19. In vivo characterization of brain metabolism by 1 H MRS, 13 C MRS and 18 FDG PET reveals significant glucose oxidation of invasively growing glioma cells. Lai M, Vassallo I, Lanz B, Poitry-Yamate C, Hamou MF, Cudalbu C, Gruetter R, Hegi ME. Int J Cancer; 2018 Jul 01; 143(1):127-138. PubMed ID: 29417580 [Abstract] [Full Text] [Related]
20. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G. J Neurosurg; 1997 Oct 01; 87(4):516-24. PubMed ID: 9322842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]